Morbidität einzeitiger Abortausräumungen im 2. Trimenon: Eine Standortbestimmung

  title={Morbidit{\"a}t einzeitiger Abortausr{\"a}umungen im 2. Trimenon: Eine Standortbestimmung},
  author={E. Pauli and Urs Haller and Roland Zimmermann},
  journal={Gyn{\"a}kologisch-geburtshilfliche Rundschau},
  pages={107 - 115}
Fragestellung: Untersuchung der Morbidität einzeitiger Abortausräumungen (Dilatation und Kürettage, D&C) im 2. Trimenon. Methoden: Retrospektive Erfassung der Frühkomplikationen von D&C im 2. Trimenon (Gruppe A: 1988–1994). Vergleich mit D&C im 1. Trimenon (Gruppe B: 1997) und der Abortinduktion durch extraamniale Prostaglandinapplikation (Literatur). Ergebnisse: D&C im 2. wies im Vergleich zum 1. Trimenon eine signifikant höhere Morbidität auf (p < 0,0001). Häufigste Komplikation in beiden… 
13 Citations
Severity of Hyperlipidemia Does Not Affect Antiatherosclerotic Effect of an Angiotensin II Receptor Antagonist in Apolipoprotein E-deficient Mice
It is concluded that the antiatherosclerotic effect of ARBs is not weakened by the high plasma cholesterol level, suggesting the usefulness of ARB in the treatment of atherosclerosis, even in a situation in which the plasma cholesterol levels are not fully controlled.
Changes in the Approach for Invasive Prenatal Diagnosis in 35,127 Cases at a Single Center from 1977 to 2004
TA-CVS is now the only technique used for β-thalassemia and karyotyping at a single center from 1977 to 2004, while cordocentesis and hepatic vein sampling have shown a decline after their introduction.
Care goals and decisions for children referred to a pediatric palliative care program.
Children with complex, life-limiting conditions and their families referred to a palliative care service commonly verbalize goals related to health maintenance and independence, and anticipating this expectation may foster communication and improve patient care.
Preferences of patients with advanced lung cancer regarding the involvement of family and others in medical decision-making.
The majority of patients with lung cancer wanted family involvement in decision-making, and almost all did so in case of future loss of competence, however, as half of the patients changed their minds over time about the degree of family involvement they wanted if they lost competence, physicians should regularly rediscuss a patient's preferences.
Surrogate decision makers for incompetent ICU patients: a European perspective
The present review compares the legal framework of surrogacy in Belgium, Denmark, England, France, Germany, the Netherlands, Spain, and Switzerland and finds France is the country that confers the weakest power to surrogates in decision making.
Reliability of an interactive computer program for advance care planning.
The purpose of this study was to demonstrate that (in the absence of major life changes) the AD generated by MYWK reliably reflects an individual's values/preferences.
Advance directives and cancer decision making near the end of life.
  • P. Ditto, N. Hawkins
  • Psychology
    Health psychology : official journal of the Division of Health Psychology, American Psychological Association
  • 2005
The authors present a social psychological analysis making explicit a series of steps that must necessarily take place if living wills are to honor the wishes of incapacitated patients.
Why doesn't a family member of a person with advanced dementia use a substituted judgment when making a decision for that person?
Several reasons why surrogate decision-makers for persons with advanced dementia do not use the substituted judgment standard are suggested and the potential value of interventions that would allow patients with early-stage dementia and their family members to discuss healthcare preferences are suggested.
Why are advance care planning decisions not implemented? Insights from interviews with Australian general practitioners.
Problems in implementation of ACPs are multifactorial and not necessarily due to deliberate nonadherence by health professionals and potential solutions to improve the clinical impact of ACP are discussed.


Abortinduktion im 2. und 3. Schwangerschaftstrimenon
Die Abortinduktion in fortgeschrittenen Schwangerschaftsstadien ist nach Ansicht verschiedener Autoren mit erheblichen Risiken behaftet (s. Ubersicht bei Haller u. Kubli 1978). Die
Aborteinleitungen im zweiten und dritten Trimenon mit »Sulproston«
: Report on 114 terminations of pregnancy during the second and third trimester of pregnancy with a new prostaglandin E2 derivative "Sulprostone". In 84 cases legal therapeutic abortions were
Midtrimester abortion. Intra-amniotic instillation of hyperosmolar urea and prostaglandin F2 alpha v dilatation and evacuation.
Although D&E appears to be safer overall in the midtrimester, for women obtaining abortion after 16 weeks, the rates of serious complications were comparable, with a relative risk of 1.0 (95% confidence interval, 0.4 to 2.5).
[Therapeutic abortions in the second trimestre of pregnancy with prostaglandine gel (author's transl)].
  • S. Heinzl
  • Medicine, Biology
    Geburtshilfe und Frauenheilkunde
  • 1978
Results of 141 therapeutic abortions in the second trimestre of pregnancy with Prostaglandine E2 gel or Prostaglandine F2 alpha gel are reported. Some required oxytocin augmentation. There were 102
Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
It is concluded that termination of pregnancy by D&E is preferable to the use of intravaginal PGE2, at least through the 15th week of gestation.
Midtrimester abortion by intracervical prostaglandin E2.
Mid-trimester abortion by dilatation and evacuation: a safe and practical alternative.
Although large, randomized trials are required to determine the appropriate role of mid-trimester abortion by this means, this method appears safe and practical through the 20th week of pregnancy.
[Cervix ripening and labor induction in therapeutic abortion in the middle and late 2d trimester using intracervical and extra-amniotic prostaglandin gel administration].
The combination of intracervical PG gel for cervical priming, extraamniotic PG Gel for labour induction and epidural anaesthesia presents a gentle and efficient method for the termination of pregnancy in the middle to late second trimester.